These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be ...
In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback